Keith Stockerl-Goldstein
Washington University School of Medicine · Stanford University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Keith Stockerl-Goldstein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:30 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04912427 · Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY DiseaseWashington University School of Medicine · terminated · Multiple Myeloma · principal investigator
- Ph2NCT04682405 · Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)Washington University School of Medicine · completed · Multiple Myeloma · principal investigator
- Ph2NCT00882895 · Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaWashington University School of Medicine · active not recruiting · Lymphoma, Non-Hodgkin · principal investigator
- N/ANCT00186095 · Mixed Chimeric Transplantation for Primary AmyloidosisStanford University · withdrawn · Amyloidosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 17:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 17:30 UTC. The ranking covers the 200 most relevant of 59 PubMed records, and a shared surname and initials can bring in a namesake. All 59 on PubMed
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.N Engl J Med · 2016724 citationsRCR 21.4
- 363 citationsRCR 9.3
- 345 citationsRCR 7.0
- 339 citationsRCR 8.6
- 318 citationsRCR 7.1
- Protective conditioning for acute graft-versus-host disease.N Engl J Med · 2005251 citationsRCR 5.2
- 176 citationsRCR 4.0
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.Biol Blood Marrow Transplant · 2015153 citationsRCR 4.9
- Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer.Biol Blood Marrow Transplant · 2000120 citationsRCR 2.0
- Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.Biol Blood Marrow Transplant · 2000112 citationsRCR 2.0